Brendan Walsh - Feb 4, 2022 Form 4 Insider Report for MAXLINEAR INC (MXL)

Role
VP, Product Line Marketing
Signature
/s/ Connie Kwong, as Attorney-in-Fact
Stock symbol
MXL
Transactions as of
Feb 4, 2022
Transactions value $
-$1,129,770
Form type
4
Date filed
2/8/2022, 04:37 PM
Previous filing
Jan 5, 2022
Next filing
Feb 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXL Common Stock Award $0 +3.7K +2.7% $0.00 141K Feb 4, 2022 Direct F1
transaction MXL Common Stock Tax liability -$127K -2.11K -1.5% $60.38 139K Feb 7, 2022 Direct F2
transaction MXL Common Stock Award $0 +6.08K +4.38% $0.00 145K Feb 7, 2022 Direct F3
transaction MXL Common Stock Tax liability -$197K -3.27K -2.26% $60.38 141K Feb 7, 2022 Direct
transaction MXL Common Stock Award $0 +4.05K +2.86% $0.00 146K Feb 7, 2022 Direct F3
transaction MXL Common Stock Tax liability -$131K -2.18K -1.5% $60.38 143K Feb 7, 2022 Direct
transaction MXL Common Stock Award $0 +10.8K +7.53% $0.00 154K Feb 7, 2022 Direct F4
transaction MXL Common Stock Tax liability -$351K -5.81K -3.77% $60.38 148K Feb 7, 2022 Direct
transaction MXL Common Stock Award $0 +7.2K +4.85% $0.00 156K Feb 7, 2022 Direct F4
transaction MXL Common Stock Tax liability -$234K -3.88K -2.49% $60.38 152K Feb 7, 2022 Direct
transaction MXL Common Stock Award $0 +1.63K +1.08% $0.00 153K Feb 7, 2022 Direct F5
transaction MXL Common Stock Tax liability -$53.1K -880 -0.57% $60.38 152K Feb 7, 2022 Direct
transaction MXL Common Stock Award $0 +1.09K +0.71% $0.00 153K Feb 7, 2022 Direct F5
transaction MXL Common Stock Tax liability -$35.4K -586 -0.38% $60.38 153K Feb 7, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock issued to the Reporting Person for the 2021 performance period under the Company's Executive Incentive Bonus Plan (the "Bonus Plan"). All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. Grant amounts were determined based on the award amount earned under the Bonus Plan and the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 4, 2022.
F2 On February 7, 2022, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 7, 2022.
F3 Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2021 fiscal year that were approved as part of the 2019 performance-based restricted stock award granted on May 20, 2019. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 7, 2022, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 7, 2022.
F4 Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2021 fiscal year that were approved as part of the 2020 performance-based restricted stock award granted on March 31, 2020. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 7, 2022, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 7, 2022.
F5 Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2021 fiscal year that were approved as part of the 2021 performance-based restricted stock award granted on May 20, 2021. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 7, 2022, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 7, 2022.